CTOs on the Move

International Association for Medical Assisance

www.iamat.org

 
International Association for Medical Assisance to Travelers is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iamat.org
  • 40 Regal Rd
    Guelph, ON CAN N1K 1B5
  • Phone: 716.754.4883

Executives

Name Title Contact Details

Similar Companies

Fulton County Health Center

Fulton County Health Center is a full service hospital and long term care facility located in Wauseon, Ohio. They offer a wide variety of programs and services, including emergency care, surgical department, and general medical care for patients of Wau...

Drake-Scruggs Equipment Inc

Drake-Scruggs Equipment Inc is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lane Regional Medical Center

At Lane Regional Medical Center, we value community and take pride in the role we play as caregivers. It is an honor to say that we serve as the primary healthcare resource for more than 200,000 of our neighbors located throughout Zachary and the surrounding region of Baker, Central, Clinton, Jackson, St. Francisville, New Roads, North Baton Rouge and Southern Mississippi. As part of our continued dedication to serving our community and providing the highest quality of care, we continue to recruit new physicians to the area and to provide access to the very best healthcare services, technologies and programs available in the region.

Scientific Connexions

Scientific Connexions is a Newtown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Geron

We are a biopharmaceutical company developing first-in-class therapies for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. Telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. Imetelstat is a potent and specific inhibitor of telomerase. Based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or MF, myelodysplastic syndromes, or acute myelogenous leukemia.